Blog

15 Articles

long-term survivor Davi D'Agostino
Survivor Stories
January 19, 2024 • 1 Min

Steely Strength to Keep Going

Long-term survivor Davi D’Agostino discovered she carries the BRCA2 mutation, which changed her treatment plan to targeted therapy.

Acinar cell pancreatic cancer patient Paul Suntup
Survivor Stories
December 27, 2023 • 7 Min

A Long Journey That Began With Pancreatitis

Paul Suntup’s diagnosis of acinar cell pancreatic cancer was just the start of a long treatment journey, but he’s still here.

Slide of pancreatic cancer
Research
August 14, 2023 • 2 Min

Targeting Pancreatic Cancer Cell Growth

Researchers are testing a new drug targeting cell growth in solid tumors, including pancreatic cancer.

Pishvaian
Research
July 27, 2023 • 4 Min

New Study Targets Specific BRAF Mutation

One type of BRAF mutation may provide a target for treatment in pancreatic cancer patients, explains Dr. Michael Pishvaian.

neon lights in the shape of DNA
Research
June 22, 2023 • 2 Min

Targeted Therapy for Cancers Carrying the PALB2 Mutation

Researchers are testing a type of targeted therapy called a PARP inhibitor for cancers carrying the PALB2 mutation.

Kenneth Yu, MD
Research
February 22, 2021 • 5 Min

Blood-Based Test Predicts What Drugs May Work Best

Dr. Kenneth Yu is testing a blood-based assay that looks at which types of chemotherapies will work best for each pancreatic cancer patient.

pancreatic cancer patient Gina Harrison and her grandsons
Survivor Stories
August 18, 2020 • 4 Min

The Value of Molecular Profiling and Genetic Testing

Gina Harrison underwent molecular profiling of her pancreatic tumor, which led her to a clinical trial. Genetic testing showed her BRCA1 mutation was random.

Fractal flame ribbons in whte and red on a black background
Research
May 15, 2020 • 2 Min

Targeted Therapy to Inhibit Connective Tissue Growth in Pancreatic Cancer

Researchers are testing a new antibody, a type of targeted therapy, in combination with standard treatment for pancreatic cancer in a phase III trial.

DNA aqua pipette
Research
February 26, 2020 • 6 Min

Exploiting DNA Mutations For Pancreatic Cancer Treatment

Dr. James Cleary explains how the researchers at Dana-Farber are looking to make PARP inhibitors even more effective for pancreatic cancer patients.

Julie Sutcliffe in her lab
Research
October 4, 2019 • 5 Min

Harnessing the Power of Radionuclide Therapy

Julie Sutcliffe is working with targeted radionuclide therapy to go after pancreatic cancer cells that have spread beyond the pancreas.

Old medicine bottles
Research
January 22, 2019 • 4 Min

A PARP Inhibitor Approval for Pancreatic Cancer

PARP inhibitors, a type of targeted therapy, are being studied as treatment for pancreatic cancer in a number of clinical trials.

Dr. Allyson Ocean
Research
January 9, 2019 • 6 Min

Pancreatic Cancer: 2018 Highlights And Looking Forward to 2019

Dr. Allyson Ocean leads an overview of the new treatments and protocol from 2018 as well as what are the next steps in treatment for 2019.

Draining board
Research
July 5, 2018 • 4 Min

A Potential Role for PARP Inhibitors in Pancreatic Cancer

Dr. Michael Pishvaian leads research into the possible role of PARP inhibitors in treating pancreatic cancer patients with certain genetic mutations.

Dr. Margaret Tempero
Research
June 23, 2017 • 4 Min

Targeted Therapy for Pancreatic Cancer

Dr. Margaret Tempero outlines the work being done in the area of targeted therapy for pancreatic cancer, specifically the testing of ibrutinib.

Cancer Moonshot meeting with Vice President Joe Biden and President Barack Obama
Research
December 30, 2016 • 4 Min

The Cancer Moonshot

Dr. Elizabeth Jaffee of Johns Hopkins is part of the Cancer Moonshot’s Blue Ribbon Panel, and she explains the goals of the program.